GSK3915393
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
GlaxoSmithKline
Overview
GSK3915393 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
GSK3915393 clinical trials
Explore related
Medical disclaimer. This page summarizes research about GSK3915393 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.